Cargando…

Redirecting host preexisting influenza A virus immunity for cancer immunotherapy

We tested the concept that host preexisting influenza A virus immunity can be redirected to inhibit tumor growth and metastasis through systemic administration of influenza A virus–related peptides to targeted tumors. Mice infected with influenza A virus strain A/Puerto Rico/8/34 (PR8) were used as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaganty, Bharat K. R., Qiu, Songbo, Lu, Yang, Lopez-Berestein, Gabriel, Ozpolat, Bulent, Fan, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563826/ https://www.ncbi.nlm.nih.gov/pubmed/34731283 http://dx.doi.org/10.1007/s00262-021-03099-9

Ejemplares similares

BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells
por: Gamain, Benoît, et al.
Publicado: (2022)

Rna Viruses Redirect Host Factors to Better Amplify Their Genome
por: Boguszewska‐Chachulska, Anna M., et al.
Publicado: (2005)

Redirecting the focus of cancer immunotherapy to premalignant conditions
por: Young, M. Rita I.
Publicado: (2017)

Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2022)

Monitoring and redirecting virus evolution
por: Moratorio, Gonzalo, et al.
Publicado: (2018)

Arming HSV-Based Oncolytic Viruses with the Ability to Redirect the Host’s Innate Antiviral Immunity to Attack Tumor Cells
por: Fu, Xinping, et al.
Publicado: (2020)

PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells
por: Ozpolat, Bulent, et al.
Publicado: (2012)

A Practical Approach to Immunotherapy of Hepatocellular Carcinoma Using T Cells Redirected Against Hepatitis B Virus
por: Koh, Sarene, et al.
Publicado: (2013)

Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
por: Mensali, Nadia, et al.
Publicado: (2019)

Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell–Redirected Bispecific Antibodies
por: Lussana, Federico, et al.
Publicado: (2021)

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2013)

Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
por: Sendker, Stephanie, et al.
Publicado: (2021)

COVID-19 in Africa: preexisting immunity and HIV
por: Snyman, Jumari, et al.
Publicado: (2021)

Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
por: Mensali, Nadia, et al.
Publicado: (2019)

Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies
por: Abbott, Rebecca C., et al.
Publicado: (2020)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Attenuation of RNA viruses by redirecting their evolution in sequence space
por: Moratorio, Gonzalo, et al.
Publicado: (2017)

The gift of preexisting immunity for developing an alternative vaccine strategy
por: Tran, Kim A., et al.
Publicado: (2023)

Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
por: Fromm, George, et al.
Publicado: (2018)

Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
por: Lin, Tsung-Yi, et al.
Publicado: (2021)

Immunotherapy of B cell lymphoma with CD22-redirected CAR NK-92 cells
por: Tian, Xiaopeng, et al.
Publicado: (2023)

Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy
por: Carrasco-Padilla, Carlos, et al.
Publicado: (2022)

Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2012)

The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

Preexisting CD4+ T-Cell Immunity in Human Population to Avian Influenza H7N9 Virus: Whole Proteome-Wide Immunoinformatics Analyses
por: Duvvuri, Venkata R., et al.
Publicado: (2014)

Host Immune Response to Influenza A Virus Infection
por: Chen, Xiaoyong, et al.
Publicado: (2018)

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2016)

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2023)

Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma
por: Li, Kesang, et al.
Publicado: (2015)

Preexisting Immunity to Pandemic (H1N1) 2009
por: Xing, Zheng, et al.
Publicado: (2009)

Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
por: Arbore, Giuseppina, et al.
Publicado: (2023)

DCs redirect T cell traffic
por: Van Epps, Heather L.
Publicado: (2005)

Redirecting splicing with bifunctional oligonucleotides
por: Brosseau, Jean-Philippe, et al.
Publicado: (2014)

Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
por: Pandey, Aseem, et al.
Publicado: (2012)

Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia
por: Do, Priscilla, et al.
Publicado: (2020)

Soluble Host Defense Lectins in Innate Immunity to Influenza Virus
por: Ng, Wy Ching, et al.
Publicado: (2012)

Redirecting T Cells against Epstein–Barr Virus Infection and Associated Oncogenesis
por: Münz, Christian
Publicado: (2020)

Preregistration of Analyses of Preexisting Data
por: Mertens, Gaëtan, et al.
Publicado: (2019)

Preexisting Conditions That Kill Us
por: Hanna-Attisha, Mona, et al.
Publicado: (2021)

Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ccbqnij9ullvj59djn2701a9j8